The skin is an interesting organ for human gene therapy due to accessibility, immunologic potential and synthesis capabilities. In this study, we attempted to visualize and measure the uptake of naked FITC-labeled plasmid by FACS analysis detecting up to 15% internalization in a doseand time-dependent manner. Cycloheximide treatment inhibited the uptake by 490%, suggesting a protein-mediated uptake. The inhibition of different internalization pathways demonstrated that blocking macropinocytosis (by amiloride and N,N-dimethylamylorid) reduced DNA uptake by 485%, while the inhibition of clathrin-coated pits (by chlorpromazine) and caveolae (by nystatin/filipin III) did not limit the uptake. Colocalization studies using confocal laser microscopy revealed a time-dependent accumulation of plasmid DNA in endosomes and lysosomes. When a green fluorescent protein (GFP) expression vector was used, specific GFP-RNA became detectable by reverse transcriptase-PCR, whereas measurable amounts of protein could not be identified in FACS experiments. To detect the potential DNA receptors on the keratinocyte surface, membrane proteins were extracted and subjected to South-Western blotting using digoxigenin-labeled calf thymus and l-phage DNA. Two DNA-binding proteins, ezrin and moesin, known as plasma membrane-actin linkers, were identified by one-and two-dimensional-South-Western blots and matrix-assisted laser desorption and ionizationmass spectrometry. Ezrin and moesin are functionally associated with a number of transmembrane receptors such as the EGF, CD44 or ICAM-1 receptor. Taken together, naked plasmid DNA seems to enter human keratinocytes through different pathways, mainly by macropinocytosis. Two DNA-binding proteins were identified that seemed to be involved in binding/trafficking of internalized DNA.
Introduction
Epidermal keratinocytes and dendritic cells have the ability to take up and express naked plasmid DNA upon intradermal in vivo injection and topical application, [1] [2] [3] [4] [5] [6] [7] making them attractive targets for gene therapy and DNA vaccination.
Various distinct forms of endocytosis were implicated in DNA uptake. [8] [9] [10] [11] Besides phagocytosis and pinocytosis that serve to internalize particles up to 2 mm in size, 12 receptor-mediated endocytosis represents a highly specific import mechanism by receptor-ligand interactions (eg the epithelial growth factor receptor), 13, 14 or by binding to more promiscuous scavenger receptors such as asialoglycoprotein or lectins. 15, 16 Inside the cytoplasm, the complex is packaged and transported as a clathrincoated vesicle to the endosomes, where disassembly occurs. 17, 18 Recent data have demonstrated the uptake of DNA into muscle cells by caveolae (potocytosis). 8, 9, 18, 19 Alternatively, McNeil et al 20 suggested that cells undergo transient membrane microdisruptions that occur, for example, in gastric epithelial cells or skin epidermal cells, when internalizing fluorescent dextrin or horseradish peroxidase. Several pieces of evidence point to receptor-mediated DNA uptake through DNAbinding proteins in lymphocytes, monocytes, neutrophils and skeletal muscle cells. [21] [22] [23] On human lymphocytes, Gasparro et al 24 have described three DNA-binding proteins (28, 59 and 79 kDa) following the hybridization with 32 P-labeled calf thymus DNA. On rabbit skeletal muscle, three DNA-binding proteins of 28, 60 and 95 kDa were identified using a 32 P-labeled double-stranded linearized pBluescript probe. 25, 26 Since gene therapy via the epidermis becomes increasingly important, 27 we attempted to elucidate the mechanism by which plasmids surmount the keratinocyte cell membrane and study their intracellular trafficking, as well as to identify DNA-binding membrane proteins.
Materials and methods

Keratinocyte culture
Primary human keratinocytes were derived as described earlier. 28 Briefly, epidermis was separated by dispase treatment of normal human skin followed by trypsin treatment to obtain a single-cell suspension of keratinocytes. Primary keratinocytes were cultured in keratinocyte growth medium (KGM) (Clonetics, San Diego, CA, USA) in a humidified atmosphere at 371C and 5% CO 2 . For confocal microscopy, keratinocytes were cultured on four-well chamber slides (Life Technologies).
Plasmid labeling
Vectors (pCMV-IL-2-b-Gal, 7.2 kb or pEGFP-N1, 4.2 kb; Clontech) were labeled using commercially available labeling kits (Cy5 or FITC Label It; Mirus, Madison, WI, USA) according to the manufacturer's instructions. The FITC label binds covalently to guanine residues of the plasmid; labeled plasmid is separated from free FITC via a G50 microspin column. 29 The labeling efficiency was confirmed by titration of the plasmid from 1 mg to 50 ng on a 1% agarose gel and visualization under UV light and fluorescence microscopy, and found not to alter their uptake and intracellular trafficking. 8, 20 FITC-labeled oligodeoxynucleotides (ODNs) were purchased from MWG Biotech, Ebersberg, Germany. ODN1: GTC GGT AAA ACT TGA GCC CT; ODN2: AGG AAC CCC TAG TGA TGG AG; ODN3: AGA TAC GAG CGC TAC CTA GG; and ODN4: AAA AAA AAA AGG TGG GTG GG.
Flow cytometry measurement of plasmid uptake
Proliferating first or second passage keratinocytes were incubated at 50% confluency for various intervals with FITC-labeled DNA. Following trypsinization (0.5% trypsin, 0.53 mM EDTA, Life Technologies) and washing with 10% fetal calf serum in phosphate-buffered saline (PBS), the cells were resuspended in FACS buffer (1 Â PBS, 1% bovine serum albumin (BSA), 0.02% NaN 3 , Sigma) and analyzed by flow cytometry (Coulter Epics s , XL3-color FACS). Living cells as indicated by propidium iodide exclusion were gated and the fraction of fluorescent keratinocytes was determined. Besides the influence of concentration (1 mg and 50 mg/ml), time (0-48 h) and temperature (incubation at 4 and 371C), the effect of active protein synthesis was assessed. An aliquot of keratinocytes was treated with trypsin (Sigma) to remove surface proteins, resuspended in KGM containing 10 mg/ ml cycloheximide (Sigma) and compared with the untreated control following incubation for 4 and 24 h, respectively.
Confocal laser microscopy
Primary human keratinocytes were treated with FITC-or Cy5-labeled plasmid DNA for up to 24 h. After incubation, the cells were washed with PBS, fixed with ice-cold methanol and subsequently washed with PBS, followed by an incubation with a polyclonal anti-ezrin antibody (1:100) in PBS (Santa Cruz Biotechnology, USA). After three washes in PBS, a 45 min incubation with Alexa s -labeled secondary antibody (diluted 1:10 in PBS) (Molecular Probes, Eugene, OR, USA) was performed at room temperature in the darkness. The cultured keratinocytes were analyzed on the glass slip, embedded in FluoroPrep s (BioMérieux, France) and evaluated under a confocal laser microscope (Carl Zeiss LSM510, Axiovert 100 M, Jena, Germany). Further contrast enhancement was carried out with Photoshop (Adobe, Mountain View, CA, USA). Nuclei were labeled with Hoechst 33258 (Sigma).
Inhibition of various internalization pathways
Keratinocyte cultures were incubated for 1 h with several inhibitors of internalization prior to the addition of FITClabeled plasmid DNA. Incubation was performed with amiloride (3 mM, Sigma) and N,N-dimethylamiloride (0.5 mM, Sigma) inhibiting macropinocytosis, 30 nystatin (10 mM, Sigma) and filipin III (23 mM, Sigma), inhibiting caveolae (potocytosis) 18 and with chlorpromazine (10 mg/ml, Sigma) that interferes and FITC dextran clathrin-coated pits, 31 respectively. FITC transferrin (Molecular Probes, Eugene, OR, USA) were used to visualize receptor-mediated uptake and clathrin-coated pits.
PCR
Keratinocyte cultures incubated with pEGFP-N1 plasmid (up to 80 mg/ml) were washed three times with PBS prior to the isolation of total RNA using the Trizolt method (Life Technologies, Karlsruhe, Germany) as described. 32 To remove contaminating DNA, RNA samples were incubated with 10 U RNAse-free DNAse I (Roche) 31 per 10 mg RNA in 0.1 ml for 1 h at 371C followed by Trizolt (Invitrogen). PCR was performed using a RNA-PCR kit (Superscriptt One Step PCR-system, Roche) on 10-50 ng of total DNAse-treated RNA with primers (forward: ACA AGT TCA GCG TGT CCG GC; reverse: TTG TGG CTG TTG TAG TTG TAC TCC AG) at the following conditions (cDNA synthesis: 501C, 30 min; one single denaturing at 941C, 2 min; PCR: 40 cycles of 941C, 30 s, 601C, 30 s and 721C, 1 min). For the Àreverse transcriptase (RT) controls, DNA-PCR was performed using 1 U of the Hot Start Polymeraset (Qiagen, Hilden, Germany) per reaction according to the manufacturer's recommendations and subsequently 35 cycles as described above.
To ensure high quality of RNA, b-actin controls were run in parallel.
Membrane protein extractions
Membrane protein fractions were obtained following a modified procedure according to Trigatti et al. 33 Human epidermis was frozen in homogenization buffer (1 mM HEPES, pH 7.4, 1 mM EDTA, 0.25 M sucrose). After homogenization (Potter S, Braun, Melsungen, Germany) on ice in the presence of a mix of proteinase inhibitors (Roche), a further freeze-thaw cycle was performed. Finally, the homogenate was pelleted at 10 000 g, 15 min, 41C and resuspended in homogenization buffer. Following a second centrifugation, the pellet was resuspended in homogenization buffer and aspirated with a 27-guage needle prior to separation on a sucrose gradient (0.87, 1.1 M, 1.5 M sucrose in 10 mM HEPES, pH 7.4, 1 mM EDTA). Following ultracentrifugation (L-60 ultracentrifuge, Beckmann) at 23 000 g, 41C for 90 min, the plasma membrane fraction located to the upper interphase between the 0.25 M sucrose of the homogenization buffer and the 0.87 M sucrose of the gradient. This interphase was removed and resuspended in the five-fold volume of ice-cold PBS prior to another ultracentrifugation at 100 000 g, 41C for 60 min. Finally, the pellet was dissolved in PBS containing 0.05 mM phenylmethylsulfonylfluoride (PMSF, Sigma).
One (1D)-and two (2D)-dimensional gel electrophoresis
Isolated protein extracts (20 mg) were prepared for electrophoresis by mixing 1:1 with sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% bromophenol blue, 5% b-mercaptoethanol, BioRad, Munich, Germany), boiled for 10 min and then chilled on ice. Proteins were separated using precast 4-20% 34 Protein extract (200 mg) were solubilized in 250 ml solubilization buffer (7 M urea, 2 M thiourea, 150 mM DTT, 4% (w/v) CHAPS, 0.5 (v/v) carrier ampholyte, pH 3.5-10 (Pharmacia BioTech, Sweden)). Undissolved proteins were removed by centrifugation at 15 000 g, 41C for 15 min. After the hydration of isoelectric focusing strips, the protein extracts were subjected to an 11 h separation protocol with increasing voltage from 150 to 2500 V and 50 mA/strip. Following the isoelectric focusing, the strip was equilibrated in buffer containing 6 M urea, 2% SDS, 50 mM Tris-HCl, 30% glycerol and 0.03% bromophenol blue, pH 8.8. DTT was added to a final concentration of 65 mM. The strip was transferred onto an 8-16% gradient gel and separation was performed in the second dimension at 40 mA/gel at 201C in running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS). Gels were stained with Gel Code Blue Stain Reagent (Pierce, Rockford, IL, USA) with colloidal Coomassie G-250 (Pierce) or silver stain kit (Biorad, Munich) according to the manufacturer's instructions.
Hybridization with digoxigenin (DIG)-labeled DNA
Following gel electrophoresis, proteins were transferred onto a PVDF membrane (Roche). HindIII-digested lphage DNA and sonicated calf thymus DNA (Sigma) were labeled with a DIG DNA-Labeling and Detection Kit (Roche). Briefly, the denatured DNA is incubated with Klenow polymerase using a deoxyribonucleoside phosphate mix that contains DIG-11-dUTP. The labeled probe was denatured and hybridized to the blocked membrane (10 mM HEPES, pH 8.0, 5% blocking reagent; Roche) for 2 h in 15 ml hybridization buffer (10 mM HEPES, pH 8.0, 50 mM NaCl, 10 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT, 0.25% blocking reagent) at a concentration of 35 ng/ml. 35 The detection of the DNA probe that bound to separated membrane proteins was performed with alkaline phosphatase-labeled anti-DIG antibodies using the DIG DNA-Labeling and Detection Kit (Roche).
Protein identification by matrix-assisted laser desorption and ionization (MALDI)-mass spectrometry
A parallel 2D SDS-PAGE was stained with Coomassie blue and used for the excision of corresponding protein spots that were identified to bind DNA in South-Western analysis. The gel spots containing the respective proteins were digested with trypsin and trifluoroacetic acid and commercially analyzed using mass spectrometry (Reflex-III, Bruker-Franzen, Bremen, Germany) at the Institute of Physiological Chemistry, Ruhr-University, Bochum, Germany. The comparison of MS spectra with known proteins was performed using the software ProFound (http://prowl.rockefeller.edu/cgi-bin/ProFound).
Immunohistology
Paraffin-embedded sections of normal skin were used for immunohistology using a monoclonal anti-ezrin antibody (0.25 mg/ml, Transduction Laboratories, Lexington, KY, USA). After several washes with 1% BSA in PBS, a secondary anti-mouse-IgG (1:30) was added with the staining being completed according to the alkaline phosphatase/antialkaline phosphatase method. 36 
Uptake inhibition by polyclonal antibodies
To assess the effect of transmembrane receptors, known to be associated with ezrin and moesin, blocking antibodies were added to the keratinocyte cultures 1 h prior to the addition of labeled plasmid DNA. Antibodies (CD44 monoclonal, Biozol, Munich, Germany; CD44 polyclonal, Chemicon, International, Temecula, CA, USA), caveolin (polyclonal, Transduction Laboratories, Lexington, KY, USA), clathrin heavy chain (monoclonal, Transduction Laboratories, Lexington, KY, USA), and ezrin (polyclonal, Santa Cruz Biotechnology, CA, USA), ezrin (monoclonal, Transduction Laboratories, Lexington, KY, USA), moesin (monoclonal, Transduction Laboratories, Lexington, KY, USA), triadin (monoclonal, mouse, Affinity Bioreagents, Golden, CO, USA), and villin (monoclonal, BioDesign International, USA) were used at the indicated concentrations.
Results
Visualization of plasmid uptake
The uptake of various FITC-, rhodamine-or Cy5-labeled DNA fragments (without the presence of transfection agents) of 20 bp to 7.2 kb in size was analyzed using confocal microscopy. While ODN were rapidly and almost completely taken up into the nucleus of keratinocytes ( Figure 1a , c and e), only a low amount of FITClabeled (Figure 1b) or Cy5-labeled plasmid (Figure 1e and f) (each 1 mg/ml) could be detected in the cytoplasm and around the nucleus after 6 h. When the effect of the lysosomotropic agent chloroquine (10 mM) was analyzed, an increased accumulation of plasmid DNA in the cells and nuclei became evident (Figure 1g-j) .
Dependence of DNA uptake on concentration, time, temperature and protein synthesis
The uptake was dependent on the concentration of the added plasmid DNA (Table 1) . At 1 mg/ml, 4.2% of keratinocytes (mean fluorescence intensity: 0.36) were FITC positive as revealed by flow cytometry; at 2 mg/ml: 10.4% (mean fluorescence intensity: 0.53); and at 5 mg/ ml: 12.6% (mean fluorescence intensity: 0.6), respectively, when analyzed after 4 h of incubation at 371C. The time dependence of plasmid uptake was clearly evident with a maximum of 14.9% at 24 h ( Table 1 ). The mean fluorescence intensity was 0.36 at 4 h, 0.38 at 8 h and 1.35 at 24 h, respectively, with no further increase thereafter. The uptake was also dependent on the temperature, since at 41C the mean fluorescence intensity was 0.49 as compared with 1.14 at 371C. Next, we investigated whether the uptake of plasmid DNA into keratinocytes depended on active protein synthesis as revealed by the protein synthesis inhibitor cycloheximide. While the mean fluorescence intensity was 0.83 at 4 h (5 mg/ml plasmid DNA) without the addition of cycloheximide, it declined to 0.47 (n ¼ 3) at 4 h when cells were exposed to cycloheximide following trypsinization.
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Inhibition studies of several internalization mechanisms
Several established mechanisms of endocytosis, utilizing clathrin-coated pits, macropinocytosis and caveolae, were studied (Figure 2a-e) . In order to evaluate the relevance of several potential internalization processes, FITC-and Cy5-labeled plasmid DNA was applied together with specific inhibitors of macropinocytosis (amilorid and N,N-dimethylamilorid), 30 potocytosis (nystatin and filipin) 18 and clathrin-coated pits (chlorpromazine) (Figure 2) . 31 The possibility that plasmid DNA was recruited into macropinocytotic vesicles was probed with amiloride and N,N-dimethylamiloride, two potent inhibitors of macropinocytosis. 30 Amiloride (and the more potent inhibitor N,N-dimethylamiloride) dramatically reduced the mean intracellular fluorescence by 10-fold (Figure 2b and e, column 2 with amiloride and 3 with N,N-dimethylamiloride, respectively; Po0.05 as compared to column 1). Since keratinocytes are known to have caveolae on their basolateral surfaces, 37 nystatin and filipin III, two inhibitors of caveolae, were found not to inhibit the uptake of plasmid DNA in keratinocytes (Figure 2d and e, column 4 with nystatin and 5 with filipin III, respectively), indicating that potocytosis does not play a significant role in uptake and transport of plasmid DNA in keratinocytes. The addition of chlorpromazine, an inhibitor of clathrincoated pits, led to a three-fold increase in mean intracellular fluorescence in five independent experiments (Figure 2c and e, columns 6 and 7), suggesting that clathrin-coated pits were not involved in the uptake of naked plasmid DNA. The observed signal intensification was probably due to toxic effects that led to keratinocyte differentiation as suggested by enlargement of keratinocytes (increased forward scatter in FACS analysis; data not shown).
Intracellular trafficking of plasmid DNA
When intracellular trafficking of Cy5-labeled plasmid DNA was analyzed together with the 10-kDa FITCdextran, a commonly used fluid-phase endocytosis marker, 38 several colocalization signals were detected as Original magnification Â 630; some images (e-h) were digitally processed to achieve higher or lower magnification. Quantification of several uptake characteristics was performed using flow cytometry. The dependence of concentration was evident (at 1 mg/ml 4.2% of keratinocytes were FITC positive; at 2 mg/ml: 10.4%; at 5 mg/ml: 12.6%, respectively), when analyzed after incubation for 4 h at 371C. The time dependence of plasmid uptake was shown with a maximum at 24 h. The mean fluorescence intensity was 0.36 at 4 h, 0.38 at 8 h and 1.35 at 24 h, respectively, with no further increase thereafter. The uptake was also dependent on the temperature, since at 41C the mean fluorescence intensity was 0.49 as compared with 1.14 at 371C. The addition of the protein synthesis inhibitor cycloheximide also reduced the intracellular fluorescence. Each n ¼ 4-5 experiments; keratinocytes were derived from different patients at the first or second passage, if not indicated otherwise. (Figure 3a-c) . Cells with the most active dextran uptake (Figure 3a ) internalized usually more plasmid DNA (Figure 3band c) . When plasmid DNA was compared with calf thymus DNA, the latter also colocalized with endosomes (data not shown). Colocalization with FITC-labeled transferrin as an indicator of receptor-mediated uptake and clathrin-coated pits showed no colocalization (data not shown). In order to identify plasmid transport into lysosomes, Cy5-labeled plasmid DNA was visualized along with lysosomes stained with LysoTracker Greent (Molecular Probes, Eugene, OR, USA) known to accumulate in acid cellular compartments (Figure 3d-i) . At 24 h, significant colocalization was detected around the nuclei (Figure 3f) , with quantitatively less plasmid DNA being present in lysosomes when compared with Cy5-labeled calf thymus DNA at 24 h (Figure 3f and i) . The large size of the DNApositive vesicles and the fact that high molecular weight polysaccharides like dextrans are preferentially taken into macropinosomes rather than micropinosomes, 38 suggested that DNA-containing vesicles were formed via macropinocytosis.
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In vitro uptake of plasmid DNA leads to expression
In order to find out, whether internalized plasmid DNA also permitted expression, the indicator plasmid pEGFP (4.2 kb) expressing green fluorescent protein (GFP) was added to keratinocyte cultures (without transfection agents). In these studies, a dose-dependent expression pattern was seen. At the highest dose (80 mg/ml) keratinocytes contained transcriptionally active GFP as assessed by RT-PCR performed on DNAse-treated RNA extracted from keratinocyte cultures (Figure 4a, lane 3) . A clear signal was seen for naked plasmid next to the same transfections in the presence of lipofectin and polyethylenimine. The appropriate controls, where the extracted RNA was used without reverse transcriptase, revealed no signal (Figure 4e, lane 8) . The integrity of RNA was confirmed by b-actin control reactions (data not shown). Corresponding FACS experiments trying to demonstrate visible amounts of GFP revealed less than 1% positive cells (data not shown).
DNA-binding proteins
Since we gained evidence that plasmid DNA could be taken up by keratinocytes upon in vitro exposure, we attempted to analyze the existence of potential DNAbinding proteins on keratinocyte membranes. Therefore, membrane proteins were prepared from epidermal lysates and compared for DNA binding with cytosolic and nuclear extracts of epidermal keratinocytes using South-Western analysis. Hybridization was performed with DIG-labeled sonicated calf thymus DNA or a DIG-labeled l-phage DNA probe digested with HindIII. Using this technique, we were able to detect three membrane proteins with DNA-binding ability (Figure 5a ). In 1D-South-Western, these proteins were estimated to have a molecular weight of 78, 80 and 98 kDa, respectively (Figure 5a, lane 1) . These proteins also bound double-stranded linearized pcDNA 3 under denaturing conditions (data not shown). In the cytosol, essentially no DNA-binding proteins were found (Figure 5a , lane 2), whereas in nuclear and membrane extracts several smaller bands o42 kDa were detected (Figure 5a, lane 1 and 3) , which probably correspond to histones (Figure 5a, lane 4) . Interestingly, in porcine mucosa, the same and additional bands of 200 and 130 kDa were detected to bind DNA (Figure 5a , lane 5).
To confirm these results, 2D gel electrophoresis was performed on 200 mg of keratinocyte membrane extracts. In 2D-South-Western blots, three DNA-binding proteins spots were identified (Figure 5b, insert) . When these spots were located and excised in a corresponding Coomassie-stained gel, their sequence could be analyzed using MALDI-mass spectrometry. Using this approach, the DNA-binding proteins were identified as ezrin and moesin, which occurred as two isoforms. Western blots with monoclonal anti-ezrin-and anti-moesin antibodies using human epidermal extracts next to a South-Western experiment revealed bands at the same position (data not shown).
To assess the effect of transmembrane receptors, known to be associated with ezrin and moesin, several blocking antibodies were added to the keratinocyte cultures 1 h prior to the addition of labeled plasmid DNA. Polyclonal antibodies against ICAM-Z and ezrin reduced intracellular fluorescence by 40% each, while antibodies against caveolin, clathrin, triadin and villin had no effect (data not shown). Quantification of four to five independent experiments using FACS revealed a six-fold reduction of plasmid uptake with amiloride (e, column 2) and a 10-fold reduction with the more potent N,N-dimethylamiloride (e, column 3; Po0.05 as compared to column 1). Column 1: uninhibited uptake; column 4: nystatin; column 5: filipin III; columns 6 and 7: chlorpromazine.
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Involvement of ezrin and moesin in ODN binding
Following the binding of plasmid DNA to ezrin and moesin, we further analyzed whether ODN also bound to keratinocyte membrane proteins and whether ezrin/ moesin played a role in this process. In gel shift and supershift assays, we found two ODN-binding membrane proteins that bound ODN independent of their sequence (Figure 6a) . Interestingly, antibodies to ezrin and moesin were able to inhibit/outcompete one band (Figure 6b , and manuscript in preparation). Thus, ezrin and moesin seem to be relevant for binding to both plasmid DNA and ODN.
Expression of ezrin in human epidermis
In cross-sections of human epidermis, the expression of ezrin was confined to the suprabasal layers of the epidermis with a cytoplasmic pattern sparing the nuclei (Figure 7a ). This pattern is reminiscent of that seen upon in vivo expression of naked DNA, 1,2 where differentiating suprabasal keratinocytes express the indicator gene most efficiently. In hair follicles, the outer root sheath with differentiating keratinocytes was also staining for ezrin (Figure 7b ), while papilla keratinocytes were negative.
Discussion
For genes to be expressed in skin and other tissues, a variety of different events have to occur. First, following intraorgan (eg intradermal) injection, naked plasmid DNA has to be transported to cells that potentially take it up. Most likely, physical pressure and the concentration gradient play an important role in this regard. Secondly, when plasmid DNA reaches the basal membrane, it has to overcome this electron-dense adhesion structure. Thirdly, transport within the epidermis has to occur and plasmid DNA has to reach the keratinocyte cell membrane. At the cell membrane, uptake into the cytoplasm may occur. When inside the cell, the majority of the plasmid will be degraded in endosomal and lysosomal compartments. 39 However, a proportion of the DNA will be released from the acidic compartments and Figure 3 Intracellular trafficking of plasmid DNA. Confocal optical sections are shown, each with two fluorescent markers, which when colocalized yield a yellow color. When Cy5-labeled plasmid DNA (b, e) was traced along with the endosomal marker FITC-10-kDa dextran (10 mg/ml) to demonstrate bulkphase endocytosis (a), several colocalization signals were seen as soon as 8 h after incubation (c). For comparison, calf thymus DNA also colocalized to endosomes, but the amount of DNA reaching the nucleus was significantly lower (data not shown). At 24 h, Cy5-labeled plasmid DNA (e) and calf thymus DNA (h) were visualized in lysosomes stained with LysoTrackert (d, g), with significantly more calf thymus DNA being detected in lysosomes (i) than plasmid DNA (f). 
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arrive at the nuclear membrane, 40 where a fraction of it may be shuffled into the nucleus for transcription to occur.
The active uptake of naked plasmid DNA by mammalian cells has not been described, but it is known that Gram-positive bacteria are transformed by the transport of single-stranded DNA through a protein pore in the bacterial membrane. Moreover, Grampositive bacteria such as Hemophilus have specific membrane receptors that enable double-stranded DNA to enter small surface vesicles. Generally, it seems unlikely that there is a special endocytosis process for DNA in mammalian cells. More likely, plasmid DNA may use an existing pathway of another molecule such as potocytosis or phagocytosis. 8, 11, 20 Whereas many of the internalization processes are only incompletely Expression of ezrin in the epidermis and hair follicles. Ezrin was confined to the suprabasal layers of the epidermis with a cytoplasmic pattern sparing the nuclei (a). In hair follicles, the outer root sheath with differentiating keratinocytes was also stained (b), while papilla keratinocytes (*) were negative.
DNA-binding proteins in keratinocytes E Basner-Tschakarjan et al understood, 39 Wolff et al 8 were the first to demonstrate that naked plasmid DNA is taken up by skeletal muscle via potocytosis. 41 Their investigations including goldlabeling electron microscopic studies led to the identification of non-nuclear double-stranded DNA-binding proteins in striated muscle, among them a 95 kDa protein identified as triadin. 25, 42 More specifically, the uptake in muscle cells depended on their differentiation state with small myotubes exhibiting the highest uptake. Consistent with our results in keratinocytes, the uptake was also temperature dependent with higher uptake (and expression) occurring at 37 than at 41C. 41 Our results suggest that for keratinocytes, DNA uptake via caveolae does not seem to be responsible, since neither nystatin or filipin III nor antibodies to caveolin-1, the major component of caveolae, affected the DNA uptake and trafficking. 9 Clathrin-coated pits, the other common mechanism of receptor-mediated endocytosis, were also excluded as the DNA-uptake route because: (1) inhibitors of clathrincoated pit formation did not reduce, but rather increase, intracellular plasmid DNA content; and (2) immunostaining for caveolae showed no colocalization with DNA (data not shown). The fact that inhibitors of endocytosis through coated pits actually lead to the accumulation of intracellular DNA may reflect the pleiotropic effects of the inhibitors, or the activation of alternative uptake systems when one route is blocked. 43, 44 Instead, bulk-phase endocytosis (macropinocytosis) seems to be the primary mechanism of plasmid DNA uptake in keratinocytes. This is substantiated by the inhibition through amiloride and N,N-dimethylamiloride and the FITC-dextran colocalization studies. 38 Very recently, a novel internalization pathway has been described for hyaluronan in a rat keratinocyte cell line that uses nonclathrin-coated endosomes in a partially receptor-mediated way. 45 In contrast to our results on the uptake of plasmid DNA, amiloride did not inhibit the internalization of hyaluronan. 45 Our experiments also show -for the first time -that a significant, albeit low amount of the internalized naked plasmid DNA is being expressed in vitro as evidenced by GFP studies. Together with the ability to take up and express plasmid DNA upon in vivo injection into the dermis, 1,2 these mechanistic data demonstrate a novel characteristic of keratinocytes. The exact mechanism by which keratinocytes internalize and transport plasmid DNA remains unknown, but a protein-mediated uptake and transport seems to be involved. Besides calciummediated transfection, 46 lysosomotropic agents such as chloroquine were found to improve the transfection of mammalian cells by interfering with several steps involved in transport and release of plasmid DNA from lysosomes. 47 Recent evidence in mice and pigs showed that other tissues may also take up plasmid DNA upon in vivo injection of a supraphysiological dose. 23, 48 According to our and others' results, ODN seem to be internalized efficiently into keratinocytes leading to rapid accumulation in the nucleus. 49, 50 Moreover, we analyzed whether ODN also bound to keratinocyte membrane proteins and whether ezrin/moesin played a role in this process. In gel shift and supershift assays, we found two ODNbinding membrane proteins, of which antibodies to ezrin and moesin were able to inhibit/outcompete one band but also found additional, as yet unidentified, proteins. For comparison, a number of ODN-binding membrane proteins has been identified on kidney epithelial cells, and keratinocyte cell lines (HaCaT and A431 cells) that have a molecular weight of 35 and 61-63 kDa. 49, 51 Since the proteins were also detected to a lesser extent in nuclear extracts, the authors hypothesized that these proteins might be involved in the uptake and nuclear transport of DNA. 49 To our knowledge, ezrin and moesin have not been described to bind DNA, neither has their involvement in intracellular trafficking of DNA been reported.
Ezrin and moesin as membrane-cytoskeleton linkers and signal transducers. Ezrin and moesin belong to a highly homologous family of proteins that connect the plasma membrane with the actin cytoskeleton at specific locations. 52, 53 In addition, ezrin and moesin are involved in signal transduction 54 and in growth control. 55 Although ezrin (and moesin) have no transmembrane portion, they are functionally associated with a variety of transmembrane receptors such as ICAM-1 and -2, CD44, CD43 and the EGF receptor. 56, 57 Ezrin, moesin and radixin are about 80% homologous in the entire amino-acid sequence. 52, 58 They contain an ahelix followed by a polyprolin stretch in ezrin and radixin before the C-terminus. Whereas the C-terminus contains binding sites for F-actin, 52 the N-terminus is used to interact with transmembrane receptors such as CD44 through a 357 amino-acid-binding protein, named EBP50 (ezrin-, radixin-, moesin-binding phosphoprotein), 59 which occurs in the apical microvilli of polarized epithelia. 60 EBP50 was found to bind to the N-terminus of ezrin, radixin and moesin. Binding sites at the Nterminus (EBP50) that are expected to interact with the intracytoplasmic portions of transmembrane receptors have not yet been characterized. The N-terminus of ezrin contains a multivalent binding site shown to interact with EBP50, Rho-GDI and to the cytoplasmic part of CD44. Besides the binding to actin, a homotypic binding of the C-terminus to the N-terminus has been described for moesin and ezrin masking the binding site for actin. 61, 62 It has been found that ezrin serves as a target for several protein kinases such as for the EGF-receptor tyrosine kinase. 13, 63, 64 For example, in A431-cells, 2 min following stimulation with EGF, phosphorylation of tyrosine residues occurs leading to the resolution of homotypic head-to-tail-binding enabling the binding of the C-terminus to F-actin. This molecular signaling is accompanied by phenotypical cell changes forming membrane ruffles and microvilli and increased endocytosis. 65 In addition, recent data showed that the association of ERM proteins with transmembrane receptors such as CD44 is regulated through Rho-dependent pathways. 62, [66] [67] [68] [69] Ezrin and moesin are expressed in human lymphocytes, monocytes and neutrophils. Totaling for up to 0.5% of total cellular protein in lymphocytes and endothelial cells. From a functional standpoint, ezrin, radixin and moesin seem to be redundant, since a moesin knockout mouse did not reveal any morphological or functional alterations on the cellular and tissue level. 70 
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In summary, ezrin and moesin were identified as DNA-binding membrane-cytoskeleton linker proteins that are involved in uptake and trafficking of DNA although -up to now -we were not able to identify transmembrane DNA-binding receptors. However, ezrin and moesin are functionally associated with a number of membrane receptors such as CD44, EGF and ICAM-1-3. Following ligand binding to some of the associated receptors, phosphorylation of ezrin occurs at the Cterminus by a special protein kinase, leading to the resolution of head-to-tail enabling the binding of actin. Within 2 min significant morphological changes occur such as the formation of microvilli, membrane ruffles and increased endocytosis. The exact mechanism of the transmembrane transport and the intracellular trafficking of plasmid DNA still remain illusive. Currently, we try to identify the DNA-binding domains within the ezrin molecule and the interactions of DNA with transmembrane receptors to further elucidate the biological function of this newly recognized property of proteins known as cytoskeleton-actin linkers.
